|1||NCT01824251||Completed||Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.||
||49||All||20 Years to 100 Years (Adult, Older Adult)||NCT01824251||NPB-01-09/C-01||April 2013||September 2015||September 2015||April 4, 2013||January 20, 2016||
|2||NCT03864185||Recruiting||The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies||
||Other / Industry||
||25||All||12 Years and older (Child, Adult, Older Adult)||NCT03864185||CAMCR-011
|RECIPE||March 28, 2019||September 30, 2021||September 30, 2021||March 6, 2019||July 8, 2019||
† Study has passed its completion date and status has not been verified in more than two years.